Overview
Shaodong Hong practices in Guangzhou, China. Hong is rated as a Distinguished expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Nasopharyngeal Carcinoma, EGFR Positive Lung Cancer, and Endoscopy.
Their clinical research consists of co-authoring 140 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 72 articles in the study of Non-Small Cell Lung Cancer (NSCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerHong isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Advanced
- EGFR Positive Lung Cancer
- Nasopharyngeal Carcinoma
- Small Cell Lung Cancer (SCLC)
- Experienced
- DiarrheaHong isExperienced. Learn about Diarrhea.
- EndoscopyHong isExperienced. Learn about Endoscopy.
- HepatitisHong isExperienced. Learn about Hepatitis.
- Hepatitis BHong isExperienced. Learn about Hepatitis B.
- Infantile NeutropeniaHong isExperienced. Learn about Infantile Neutropenia.
- Lung AdenocarcinomaHong isExperienced. Learn about Lung Adenocarcinoma.